Current Drug Targets - CNS & Neurological Disorders

Aims & Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) ...read more

  • ISSN (Print): 1568-007X
  • ISSN (Online): 1568-007X
  • Volume: 4
  • Issues: 6, 2005
2.628
Current Drug Targets - CNS & Neurological Disorders

Volume 4, Issue 6, 2005

Editorial [Hot Topic:The Endocannabinoid System in the Brain: From Biology to Therapy (Guest Editor: Mauro Maccarrone)]

Pp: 613-613

Author(s): Mauro Maccarrone

DOI: 10.2174/156800705774933078

Endocannabinoid Metabolic Pathways and Enzymes

Pp: 615-623

Author(s): Alessia Ligresti, Maria G. Cascio and Vincenzo D. Marzo

DOI: 10.2174/156800705774933104

Molecular Biology of the Enzymes that Degrade Endocannabinoids

Pp: 625-631

Author(s): Robyn A. Puffenbarger

DOI: 10.2174/156800705774933050

Endocannabinoids in the Central Nervous System: From Neuronal Networks to Behavior

Pp: 633-642

Author(s): Ester Fride

DOI: 10.2174/156800705774933069

Endocannabinoids and Drug Dependence

Pp: 643-655

Author(s): Daniela Parolaro, Daniela Vigano and Tiziana Rubino

DOI: 10.2174/156800705774933014

Endocannabinoids in Neuroimmunology and Stress

Pp: 657-665

Author(s): Erica J. Carrier, Sachin Patel and Cecilia J. Hillard

DOI: 10.2174/156800705774933023

From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases

Pp: 667-675

Author(s): Anna M. Malfitano, Giuseppe Matarese and Maurizio Bifulco

DOI: 10.2174/156800705774933087

Cannabinoids: Between Neuroprotection and Neurotoxicity

Pp: 677-684

Author(s): Yosef Sarne and Raphael Mechoulam

DOI: 10.2174/156800705774933005

Pharmacological Properties and Therapeutic Possibilities for Drugs Acting Upon Endocannabinoid Receptors

Pp: 685-696

Author(s): Christopher J. Fowler

DOI: 10.2174/156800705774933041

Therapeutic Perspectives of Inhibitors of Endocannabinoid Degradation

Pp: 697-707

Author(s): Silvia Ortega-Gutierrez

DOI: 10.2174/156800705774933032

Partial QSAR Analysis of Some Selected Natural Inhibitors of FAAH Suggests a Working Hypothesis for the Development of Endocannabinoid- Based Drugs

Pp: 709-714

Author(s): Enrico Dainese, Valeria Gasperi and Mauro Maccarrone

DOI: 10.2174/156800705774933096